| A Research Study to Examine the Difference Between Local Anesthetics Alone and Local Anesthetics Plus Steroids in the Treatment of Chronic Headache (NCT00203294) | Thomas Jefferson University | 2005-06-01 |
| Study to Test a Marketed Drug in the Treatment of Menstrual Migraine (0462-072) (NCT00111722) | Organon and Co | 2005-05-27 |
| Oral Dexamethasone for Treatment of Migraine (NCT00216736) | The Joseph Epstein Centre for Emergency Medicine Research | 2005-04-01 |
| Evaluating the Safety and Tolerability of OraVescent Fentanyl for Opioid Tolerant Patients With Noncancer Related Breakthrough Pain (NCT00228605) | Cephalon | 2005-03-01 |
| A Trial to Study of the Effects of Eletriptan 40mg on Mild vs Moderate to Severe Pain Intensity of Migraine (NCT00174395) | Pfizer's Upjohn has merged with Mylan to form Viatris Inc. | 2005-03-01 |
| Study Designed to Evaluate the Safety of Prophylactic Depakote ER in the Treatment of Adolescents With Migraine (NCT00195806) | Abbott | 2005-02-01 |
| The Role of CGRPand Nociceptin in Migraine (NCT00155129) | National Taiwan University Hospital | 2005-01-01 |
| A Study of the Effectiveness and Safety of Almotriptan Versus Placebo in the Treatment of Migraine Headache (NCT00210509) | Janssen-Ortho LLC | 2004-11-01 |
| Study to Test an Approved Product in the Early Treatment of Migraine (0462-066) (NCT00095004) | Organon and Co | 2004-10-21 |
| Hemodynamic and Headache-Inducing Effect of Intravenous Vasoactive Intestinal Peptide in Migraineurs (NCT00272896) | Danish Headache Center | 2004-10-01 |
| A Controlled Trial to Investigate the Efficacy and Safety of Frovatriptan to Prevent Menstrual Migraine (NCT00475514) | Endo USA Inc., a Keenova Therapeutics Company | 2004-10-01 |
| An Open Label Extension of a Study Comparing Topiramate and Amitriptyline in Migraine Prevention. (NCT00210860) | Johnson & Johnson Pharmaceutical Research & Development, L.L.C. | 2004-09-01 |
| Study to Test an Approved Product in the Early Treatment of Migraine (0462-065) (NCT00092963) | Organon and Co | 2004-08-17 |
| Staccato Prochlorperazine Single Dose PK Study (NCT00610727) | Nova Pneuma Inc. | 2004-08-01 |
| Prospective Survey of Menstrual Migraine & Prevention With Eletriptan (NCT00259649) | University of Pittsburgh | 2004-08-01 |
| Zonisamide for Fibromyalgia & Migraine (NCT00259636) | University of Pittsburgh | 2004-08-01 |
| ZAP, US. Zomig for Appropriate for Primary Care (NCT00637286) | AstraZeneca | 2004-07-01 |
| The Diameter of the Middle Cerebral Artery Measured With Magnetic Resonance Angiography (NCT00256802) | Danish Headache Center | 2004-06-01 |
| Family Study of Affective and Anxiety Spectrum Disorders (NCT00071786) | National Institute of Mental Health (NIMH) | 2004-05-21 |
| Evaluation of Histamine, CGRP and VIP as Markers for Activation of Trigeminal and Parasympathetic Nerve Fibers (NCT00208065) | Clinvest | 2004-05-01 |
| A Research Study Examining the Use of Olanzapine for the Prevention of Migraine (NCT00203307) | Thomas Jefferson University | 2004-05-01 |
| Comparing the Safety and Effectiveness of Topiramate With the Safety and Effectiveness of Amitriptyline in Preventing Migraine Headaches (NCT00210821) | Johnson & Johnson Pharmaceutical Research & Development, L.L.C. | 2004-02-01 |
| Thrombophilia and Migraine, Are They Related? (NCT00457184) | HaEmek Medical Center, Israel | 2004-01-01 |
| A Study Examining the Use of a Migraine Medicine in the Treatment of Two Migraine Attacks in Patients Who Have Increased Skin Sensitivity (NCT00203268) | Thomas Jefferson University | 2003-12-01 |
| Safety and Tolerability of Frovatriptan to Prevention of Menstrually Associated Migraine (MAM) Headaches (NCT01035983) | Endo USA Inc., a Keenova Therapeutics Company | 2003-12-01 |
| The Effectiveness and Safety of Topiramate on Prevention of Chronic Migraine (NCT00216606) | Janssen Pharmaceutica N.V., Belgium | 2003-12-01 |
| The Prolonged Use of Topiramate for Preventing Migraine Headaches (NCT00216619) | Janssen Pharmaceutica N.V., Belgium | 2003-11-01 |
| Efficacy of Zolmitriptan (Zomig) in the Treatment of Migraines in Adolescents (NCT00617695) | Impax Laboratories, LLC | 2003-09-01 |
| A Study of the Effectiveness and Safety of Topiramate Versus Placebo for Preventing Chronic Migraine Headaches (NCT00210912) | Johnson & Johnson Pharmaceutical Research & Development, L.L.C. | 2003-09-01 |
| A Study of 3 Dosage Strengths of Almotriptan Malate (AXERT®) in the Treatment of Acute Migraine in Adolescents (NCT00210483) | Janssen-Ortho LLC | 2003-07-01 |
| The Safety and Efficacy of Divalproex Sodium Extended-Release Tablets in Migraine Prophylaxis: A Study in Adolescents (NCT00195741) | Abbott | 2003-05-01 |
| A Study Comparing the Effectiveness and Safety of ULTRACET® (Tramadol HCl/Acetaminophen) Versus Placebo for the Treatment of Acute Pain From a Migraine Headache (NCT00297375) | Johnson & Johnson Pharmaceutical Research & Development, L.L.C. | 2003-04-01 |
| A Drug Interaction Study of the Pharmacokinetics of Topiramate and FLUNARIZINE When Given Together or Separately (NCT00752466) | Johnson & Johnson Pharmaceutical Research & Development, L.L.C. | 2003-03-01 |
| Efficacy and Safety Study of Dysport® Used for Migraine Prophylaxis (NCT00301665) | Ipsen | 2003-02-01 |
| Efficacy and Safety of Eletriptan for the Treatment of Migraine in Patients Not Satisfied With Rizatriptan Therapy (NCT00632385) | Pfizer's Upjohn has merged with Mylan to form Viatris Inc. | 2003-01-01 |
| Safety and Efficacy of Eletriptan for the Treatment of Migraine in Subjects Unsuccessfully Treated With Nonsteroidal Anti-inflammatory Drugs (NCT00634985) | Pfizer's Upjohn has merged with Mylan to form Viatris Inc. | 2002-11-01 |
| Efficacy and Tolerability of Zolmitriptan Nasal Spray (NCT00617747) | AstraZeneca | 2002-09-01 |
| Treatment of Menstrual Migraine With Sequential, Transdermal, 17-Beta-Estradiol. A Double-Blind, Randomised, Cross-Over Trial. (NCT00204074) | University Hospital, Linkoeping | 2001-10-01 |
| A Comparison of the Efficacy and Safety of Topiramate Versus Placebo in Preventing Migraine Headaches in Children (NCT00237302) | Ortho-McNeil Neurologics, Inc. | 2001-07-01 |
| A Study of the Efficacy and Safety of Two Doses of Topiramate Compared to Placebo and Propranolol in the Prevention of Migraine (NCT00236561) | Johnson & Johnson Pharmaceutical Research & Development, L.L.C. | 2001-04-01 |
| A Study of the Efficacy and Safety of Topiramate in the Prevention of Migraine (NCT00231595) | Johnson & Johnson Pharmaceutical Research & Development, L.L.C. | 2001-03-01 |
| A Study of the Efficacy and Safety of Topiramate in the Prevention of Migraine (NCT00236509) | Johnson & Johnson Pharmaceutical Research & Development, L.L.C. | 2001-02-01 |
| Clinical Applications of High-Frequency Oscillations (NCT00600717) | Children's Hospital Medical Center, Cincinnati | 2000-11-01 |
| A Study of the Effectiveness and Safety of Topiramate for the Prevention of Migraine (NCT00253175) | Johnson & Johnson Pharmaceutical Research & Development, L.L.C. | 2000-10-01 |
| Exploring the Comorbidity Between Mental Disorders and General Medical Conditions (NCT03847753) | University of Aarhus | 2000-01-01 |
| Migraine and Recurrent Abdominal Pain in Children (NCT00060619) | Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) | 1999-05-01 |
| Psychological Assessment and Treatment of Chronic Benign Headache (NCT00018811) | US Department of Veterans Affairs | 1999-04-01 |
| Double-blind, Placebo-controlled Study of BGC20-1531 in Migraine (NCT00888680) | Boston Scientific Corporation | |
| An Open-label, Intermediate Size, Expanded Access Study of BHV-3000 in the Acute Treatment of Migraine (NCT03934086) | Pfizer | |
| Fremanezumab Managed Access Program for Pediatric Patients (NCT03539393) | Teva Branded Pharmaceutical Products R&D LLC | |